WALLEYE CAPITAL LLC Celldex Therapeutics, Inc. Transaction History

WALLEYE CAPITAL LLC portfolio value:

$4.83M
portfolio value

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 171.90K shares 4.83M $28.11 171.90K
Q2 2022 share Decrease -100.00% -37.38K shares -1.27M $26.96 0
Q1 2022 share Increase +162.75% 23.15K shares 723K $34.06 37.38K
Q4 2021 share Increase 0.00% 14.22K shares 550K $38.9 14.22K